Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 14, 2011

Drug Name	Review Type	Class	Manufacturer
Complera	New Drug Initial Review	HIV	Gilead
Brilinta	New Drug Initial Review	Platelet Aggregation Inhibitor	AstraZeneca
Edarbi	New Drug Initial Review	Angiotensin II Receptor Blocker	Takeda
Daliresp	New Drug Initial Review	PDE4 Inhibitor	Forest
Pradaxa	New Drug Appeal	Direct Thrombin Inhibitor	Boehringer-Ingelheim
Incivek	New Drug Appeal	Hepatitis C	Vertex
Onglyza	New Drug Appeal	DPP-4 Inhibitor	BMS
Latuda	New Drug Appeal	Atypical Antipsychotic	Sunovion
Exelon Patch	PDL Appeal	Alzheimers	Novartis